Trifluoroacetic acid → HCID 118272498, compound
Reaction equation
[C:1]([O:4][CH2:5][C:6]1[C:11]2[C:12]([O:15][CH3:16])=[N:13][NH:14][C:10]=2[CH:9]=[C:8]([NH:17][C:18]([NH:20][C@@H:21]([C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[CH3:22])=[O:19])[N:7]=1)(=[O:3])[CH3:2].[B-](F)(F)(F)[F:30].[B-](F)(F)(F)F.C1[N+]2(CCl)CC[N+](F)(CC2)C1.C(O)(C(F)(F)F)=O>CO>[C:1]([O:4][CH2:5][C:6]1[C:11]2[C:12]([O:15][CH3:16])=[N:13][NH:14][C:10]=2[C:9]([F:30])=[C:8]([NH:17][C:18]([NH:20][C@@H:21]([C:23]2[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=2)[CH3:22])=[O:19])[N:7]=1)(=[O:3])[CH3:2]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
(R)-(3-methoxy-6-(3-(1-phenylethyl)ureido)-1H-pyrazolo[4,3-c]pyridin-4-yl)methyl acetate (108 mg, 0.282 mmol, Example 257, derived from Intermediate 41B according to Scheme 3/Method A) was dissolved in MeOH (1 mL) and charged with selectfluor (150 mg, 0.423 mmol). The reaction was allowed to stir overnight at rt. The solvents were removed in vacuo and the residue was purified on RP-HPLC 30×150 mm column (25-60% CH3CN/H2O w/0.1% TFA) to provide (R)-(7-fluoro-3-methoxy-6-(3-(1-phenylethyl)ureido)-1H-pyrazolo[4,3-c]pyridin-4-yl)methyl acetate (60 mg, 0.149 mmol, 53.1% yield) as TFA salt.
Workup
- customThe solvents were removed in vacuo
- customthe residue was purified on RP-HPLC 30×150 mm column (25-60% CH3CN/H2O w/0.1% TFA)
Sources & evidence
- ORD record
- ord-8384bcb444c245618a9d8f563f54bdb5
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09226922B2
Reaction notes
Loading…